Vanadocene dichloride induces apoptosis in HeLa cells through depolymerization of microtubules and inhibition of Eg5

Susobhan Mahanty1, Darpan Raghav1, Krishnan Rathinasamy2

  • 1School of Biotechnology, National Institute of Technology Calicut, Calicut, Kerala, 673601, India.

Insights

Vanadocene dichloride (VDC) inhibits cancer cell proliferation and induces apoptosis by disrupting microtubule dynamics and inhibiting Eg5 motor protein activity, revealing its anticancer mechanism.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Vanadocene dichloride (VDC) is a vanadium metallocene dihalide with demonstrated anticancer potential.
  • The precise mechanism of VDC's anticancer activity is not fully understood, with various targets and pathways proposed.

Purpose of the Study:

  • To elucidate the mechanism of action behind vanadocene dichloride's (VDC) antiproliferative and apoptotic effects on mammalian cancer cells.
  • To investigate VDC's impact on cellular processes, including mitochondrial function, microtubule dynamics, and key mitotic proteins.

Main Methods:

  • Assessed VDC's effects on cancer cell proliferation and apoptosis, including mitochondrial membrane potential and bcl2/bax expression.
  • Analyzed VDC's impact on microtubule polymerization, depolymerization, and microtubule-kinetochore interactions.
  • Investigated VDC's direct binding to tubulin and its effect on microtubule assembly dynamics.
  • Examined VDC's interaction with and inhibition of the mitotic kinesin Eg5 ATPase activity.

Main Results:

  • VDC inhibited cancer cell proliferation and induced apoptosis via mitochondrial pathways.
  • VDC caused microtubule depolymerization, mitotic arrest with monopolar spindles, and inhibited microtubule reassembly.
  • VDC bound to tubulin at a novel site, inhibiting microtubule polymerization and altering tubulin structure.
  • VDC inhibited the ATPase activity of the mitotic kinesin Eg5.

Conclusions:

  • VDC's anticancer activity stems from its disruption of microtubule assembly dynamics.
  • Inhibition of Eg5 kinesin ATPase activity by VDC contributes to its antimitotic effects.
  • Combined disruption of microtubule dynamics and Eg5 inhibition presents a plausible mechanism for VDC's antiproliferative and antimitotic actions.

Related Concept Videos

Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.1K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.3K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.0K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.2K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
12.5K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
7.0K